Journey Medical annual r&d spending
2021
2022
2023
2024
2025
Journey Medical R&D Spending Growth & History (DERM)
Journey Medical's r&d spending was $480,000 for fiscal 2025.
View full Journey Medical company overviewJourney Medical annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $480,000 | −$9.4M | −95.13% |
| 2024 | 2024-12-31 | $9.9M | $2.3M | +30.71% |
| 2023 | 2023-12-31 | $7.5M | −$3.4M | −31.09% |
| 2022 | 2022-12-31 | $10.9M | $8.2M | +299.53% |
| 2021 | 2021-12-31 | $2.7M | — | — |
Journey Medical quarterly r&d spending
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $54,000 | $54,000 | — |
| Q1 2026 | 2026-03-31 | $0 | −$39,000 | — |
| Q4 2025 | 2025-12-31 | $154,000 | −$64,000 | −29.36% |
| Q3 2025 | 2025-09-30 | $287,000 | −$555,000 | −65.91% |
| Q2 2025 | 2025-06-30 | $0 | −$913,000 | — |
| Q1 2025 | 2025-03-31 | $39,000 | −$7.8M | −99.51% |
| Q4 2024 | 2024-12-31 | $218,000 | −$1.3M | −85.51% |
| Q3 2024 | 2024-09-30 | $842,000 | −$1.4M | −62.23% |
| Q2 2024 | 2024-06-30 | $913,000 | −$861,000 | −48.53% |
| Q1 2024 | 2024-03-31 | $7.9M | $5.9M | +287.80% |
| Q4 2023 | 2023-12-31 | $1.5M | −$2.8M | −64.64% |
| Q3 2023 | 2023-09-30 | $2.2M | −$583,000 | −20.73% |
| Q2 2023 | 2023-06-30 | $1.8M | −$835,000 | −32.00% |
| Q1 2023 | 2023-03-31 | $2.0M | $767,000 | +60.58% |
| Q4 2022 | 2022-12-31 | $4.3M | — | — |
| Q3 2022 | 2022-09-30 | $2.8M | $2.1M | +291.64% |
| Q2 2022 | 2022-06-30 | $2.6M | $2.6M | +8896.55% |
| Q1 2022 | 2022-03-31 | $1.3M | — | — |
| Q3 2021 | 2021-09-30 | $718,000 | — | — |
| Q2 2021 | 2021-06-30 | $29,000 | — | — |
Journey Medical r&d spending trends
Between the periods ended 2021-12-31 and 2025-12-31, Journey Medical's r&d spending decreased from $2.7M to $480,000, a change of −$2.3M. The latest reported quarter, Q2 2026, shows $54,000.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Journey Medical source filings ↗